DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lipocine Inc. (LPCN)
« Back to company indexLPCN Chatter Timeline
Stock Ticker for LPCN
Most Active Tweeters for LPCN
| User | Tweets |
|---|---|
| @SwingTradeBot | 2 |
| @mmahotstuff1 | 2 |
| @mido2695 | 2 |
| @jensen24000 | 2 |
| @ChartMill | 2 |
Recent Tweets for LPCN
 |
@ChartMill $LPCN: The EPS growth is accelerating: in the next 2 years the growth will be better than in the last years.… https://t.co/ZFNn2i5nES April 19th 2019, 7:04am |
 |
@ZacksSmallCap $LPCN: Solid Marketing Message if Approved https://t.co/mJvdOobQYF by @vanjohn10 https://t.co/4ZMkNRC2gW April 18th 2019, 10:04am |
 |
@TheMarketsDaily Lipocine $LPCN Trading Down 11.2% https://t.co/tzPmPw4zXK April 17th 2019, 11:04am |
 |
@stocknewstimes Lipocine $LPCN Shares Down 11.2% https://t.co/VQChxDmquL April 17th 2019, 11:04am |
 |
@runbkswm1 $lpcn Nice bounce from $1.52 April 17th 2019, 11:04am |
 |
@Togothetweettim @adamfeuerstein No Lipocine $LPCN on the list of NASH contenders? Maybe better referred to as a "participent"? April 17th 2019, 8:04am |
|
@jensen24000 $LPCN why would they file NDA if legally now they can't launch it? Wouldn't they have to win the court case first? April 17th 2019, 8:04am |
 |
@VGaykin $LPCN ww for bounce https://t.co/2QixDBVpmv April 17th 2019, 12:04am |
|
@ChartMill A Current Ratio of 4.63 indicates that $LPCN has no problem at all paying its short term obligations.… https://t.co/9hnjLnXHzD April 16th 2019, 10:04pm |
 |
@TopStockAlerts1 $LPCN Breaking out. Solid move so far. Will be watching closely tomorrow. Stay tuned!!! April 16th 2019, 6:04pm |
|
@jensen24000 $LPCN this Claurus drama seems never ending April 16th 2019, 5:04pm |
 |
@bkfViking123 from what i am looking at ...... a big threat to #nash plays ... is $lpcn before it happens ... throw that one around April 16th 2019, 3:04pm |
|
@mido2695 @bkfViking123 Any idea what’s going on with $lpcn ? April 16th 2019, 10:04am |
 |
@mmahotstuff1 What Will Happen to Lipocine Inc $LPCN Next? The Stock Has Decline in Shorts https://t.co/Xpr99Yg11g April 16th 2019, 8:04am |
 |
@SwingTradeBot 200 DMA Support today: $LPCN ... https://t.co/LjP7KUcNnp April 15th 2019, 1:04pm |
|
@SwingTradeBot Fell Below 50 DMA today: $LPCN $OPHT ... https://t.co/j2lcQOTpfA April 12th 2019, 2:04pm |
 |
@thefinreviewer Aquinox Pharmaceuticals Inc. $LPCN Contrasting side by side https://t.co/tcn8efz9ad April 12th 2019, 1:04am |
 |
@TickerReport Lipocine Inc $LPCN Expected to Post Earnings of -$0.15 Per Share https://t.co/6qISXjcgq9 April 11th 2019, 5:04pm |
 |
@dailypoliticaln Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.15 Per Share https://t.co/UGn7oLjdIF April 11th 2019, 5:04pm |
 |
@ez_scans $LPCN (( l3_lbbb ))=lower bband bounce April 11th 2019, 9:04am |
|
@mido2695 @bkfViking123 what’s the play with $LPCN here? April 10th 2019, 11:04am |
|
@mmahotstuff1 Lipocine Inc $LPCN's Stock Is Buy After Less Market Selling https://t.co/cCACKb5jBE April 9th 2019, 11:04am |
 |
@bibeypost_stock Is Buying Lipocine Inc $LPCN Here Good Idea? https://t.co/CBCLtDbf5H April 9th 2019, 11:04am |
 |
@reurope_stock Is Lipocine Inc $LPCN’s Fuel Running High? Reports Show Less Sellers https://t.co/Tmd9faRdp1 April 9th 2019, 11:04am |
 |
@macondailynews -$0.15 EPS Expected for Lipocine Inc $LPCN This Quarter https://t.co/p1mA4YicPG April 9th 2019, 11:04am |
|
@dakotafinancial Lipocine Inc $LPCN Expected to Post Earnings of -$0.15 Per Share https://t.co/VpwzxWVQmc April 9th 2019, 11:04am |
 |
@bulletin_en As of Apr 7, 2019 Lipocine Inc $LPCN Sellers Decreased Their Shorts By 61.05% https://t.co/i7PycY63JJ April 7th 2019, 12:04pm |
 |
@ConsumerFeed Zacks: Brokerages Anticipate Lipocine Inc $LPCN Will Announce Earnings of -$0.15 Per Share https://t.co/uDYjai8wnR April 7th 2019, 12:04pm |
|
@SwingTradeBot Outside Day today: $LPCN $SYNH ... https://t.co/Ya1wmaeD73 April 5th 2019, 11:04am |
 |
@endpts Citing patent infringement, Lipocine sues Clarus; Sangamo, DBV unveil share offerings https://t.co/2dk0rDfpZp $LPCN April 5th 2019, 2:04am |
 |
@WatchlistN -$0.15 Earnings Per Share Expected for Lipocine Inc $LPCN This Quarter https://t.co/sCJlgohi9n April 4th 2019, 4:04am |
 |
@ContentCarnivor $LPCN Black Box Likely with Approval https://t.co/H0eQKCyK9B $LPCN #biotech @vanjohn10 https://t.co/wCzSTJKQXk April 3rd 2019, 8:04pm |
 |
@ahighelevation $LPCN Black Box Likely with Approval https://t.co/Pr70pXvYxU $LPCN #biotech @vanjohn10 https://t.co/J2O9tz0n4l April 3rd 2019, 4:04pm |
 |
@risk_averse_ $LPCN Black Box Likely with Approval https://t.co/lsOwD7OlRS $LPCN #biotech @vanjohn10 https://t.co/tpWLcNh7cR April 3rd 2019, 3:04pm |
 |
@YMuer RT @StockNewsNow: $LPCN Lipocine Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for Testosterone Replacement Thera… April 3rd 2019, 3:04pm |
 |
@StockNewsNow $LPCN Lipocine Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for Testosterone Replacement… https://t.co/KDqs6CRI0F April 3rd 2019, 2:04pm |
|
@YMuer RT @LifeSciAdvisors: Lipocine $LPCN Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for Testosterone Replacement Th… April 3rd 2019, 12:04pm |
 |
@AnalystsAnalyst $LPCN Black Box Likely with Approval https://t.co/rXSyxMFFsI $LPCN #biotech @vanjohn10 https://t.co/jx8fefAdWY April 3rd 2019, 12:04pm |
 |
@ZacksAwareness $LPCN Black Box Likely with Approval https://t.co/pnlFT7qGBn $LPCN #biotech @vanjohn10 https://t.co/A8PEgdksnD April 3rd 2019, 12:04pm |
 |
@LifeSciAdvisors Lipocine $LPCN Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for Testosterone Replacement… https://t.co/YXRnBcV0PK April 3rd 2019, 11:04am |
 |
@vanjohn10 Following Jatenzo approval, $LPCN seeks injunction against marketing the drug. Turning the tables on Clarus. https://t.co/Tj3AwX6bQx April 3rd 2019, 11:04am |
 |
@BioStocks $LPCN Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for TRT. $LPCN PR -… https://t.co/z8w5CsRSHC April 3rd 2019, 10:04am |
 |
@newswelldone $LPCN: Lipocine Seeks Injunction Against the Marketing of Clarus …: https://t.co/OUoi0HXhGb April 3rd 2019, 9:04am |
 |
@confcalltran Lipocine Seeks Injunction Against The Marketing Of Clarus Therapeutics’ Jatenzo® For Testostero https://t.co/VkU9WaklPr $LPCN April 3rd 2019, 9:04am |
 |
@tzack16 $LPCN Black Box Likely with Approval https://t.co/R7XK8Pl0gr $LPCN #biotech @vanjohn10 https://t.co/ypR5Vic5hF April 2nd 2019, 11:04pm |
 |
@zackcappsocial $LPCN Black Box Likely with Approval https://t.co/yWMDHDE6Ng $LPCN #biotech @vanjohn10 https://t.co/Z3VxvKOJiB April 2nd 2019, 9:04pm |
 |
@TheTruthStudio $LPCN Black Box Likely with Approval https://t.co/5QgdqdyHEL $LPCN #biotech @vanjohn10 https://t.co/Eyk1xiWvXt April 2nd 2019, 7:04pm |
 |
@zackcapp $LPCN Black Box Likely with Approval https://t.co/t9sawBxYrG $LPCN #biotech @vanjohn10 https://t.co/juEYRrSzmn April 2nd 2019, 5:04pm |
 |
@InstitutionalZC $LPCN Black Box Likely with Approval https://t.co/HNoPXt8yWF $LPCN #biotech @vanjohn10 https://t.co/tKLWFGWizY April 2nd 2019, 5:04pm |
 |
@HowieRegay $LPCN Black Box Likely with Approval https://t.co/rZJCy1MVIi $LPCN #biotech @vanjohn10 https://t.co/xzHCelCkWQ April 2nd 2019, 3:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.